白藜芦醇治疗炎症性肠病的研究进展

摘要
图/表
参考文献
相关文章 (15)

［1］Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases： antibiotics,probiotics and prebiotics\[J\]. Gastroenterology, 2004,126(6):1620-1633.

［2］Nonomura S, Kanagawa H, Makimoto A. Chemical constituents of polygonaceous plants. Ⅰ.studies on the components of KOJOKON. (Polygonum cuspidatum sieb. ET ZUCC.) \[J\].Yakugaku Zasshi,1963, 83:988-990.

［3］Clarke JO，Mullin GE．A review of complementary and alternative approaches to immunomodulation \[J\]．Nutr Clin Pract,2008，23(1): 49-62.

［4］周美娟，朱春燕．白藜芦醇生物学活性研究进展 \[J\]. 当代生物医学进展，2008，8(11)：2140-2142.

［5］Gao X，Deeb D，Media J，et al．Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects\[J\]．Biochem Pharmacol，2003，66( 12) : 2427-2435．

［6］Falchetti R，Fuggetta MP，Lanzilli G，et al．Effects of resveratrol on human immune cell function \[J\]．Life Sci，2001，70(1) : 81-96．

［7］Radkar V,Hardej D,LauCam C, et al. Evaluation of resveratrol and piceatannol cytotoxicity in macrophages, T cells, and skin cells \[J\]. Arh Hig Rada Toksikol, 2007, 58(3):293-304.

［8］Feng YH, Zhou WL, Wu QL, et al. Low dose of resveratrol enhanced immune response of mice \[J\]. Acta Pharmacol Sin, 2002, 23(10):893-897.

［9］Sharma S，Chopra K，Kulkarni SK，et al．Resveratrol and curcumin suppress immune response through CD28/CTLA4 and CD80 costimulatory pathway \[J\]．Clin Exp Immunol，2007，147 ( 1) : 155-163．

［10］Seyyedebrahimi S, Khodabandehloo H, Nasli Esfahani E, et al．The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, doubleblind, placebocontrolled clinical trial\[J\]. Acta Diabetol, 2018, 55(4):341-353.

［11］Boscolo P，del SA，Sabbioni E，et al．Effects of resveratrol on lymphocyte proliferation and cytokine release \[J\]．Ann Clin Lab Sci，2003，33( 2) : 226-231．

［12］Capeleto D, Barbisan F, Azzolin V, et al．The antiinflammatory effects of resveratrol on human peripheral blood mononuclear cells are influenced by a superoxide dismutase 2 gene polymorphism \[J\]. Biogerontology, 2015, 16(5):621-630.

［13］Gualdoni GA, Kovarik JJ, Hofer J, et al．Resveratrol enhances TNFα production in human monocytes upon bacterial stimulation \[J\]. Biochim Biophys Acta, 2014, 1840(1):95-105.

［14］Jhou JP, Chen SJ, Huang HY, et al．Upregulation of FcγRIIB by resveratrol via NFκB activation reduces Bcell numbers and ameliorates lupus \[J\]. Exp Mol Med, 2017, 49(9):e381.

［15］Zunino SJ, Storms DH. Resveratrol alters proliferative responses and apoptosis in human activated B lymphocytes in vitro\[J\]. J Nutr, 2009, 139(8):1603-1608.

［16］Wang ZL, Luo XF, Li MT, et al．Resveratrol possesses protective effects in a pristaneinduced lupus mouse model \[J\]. PLoS One, 2014, 9(12):e114792.

［17］Ma C, Wang Y, Dong L, et al．Antiinflammatory effect of resveratrol through the suppression of NFκB and JAK/STAT signaling pathways \[J\]. Acta Biochim Biophys Sin (Shanghai), 2015, 47(3):207-213.

［18］Wang Z, Wu Y, Wang J, et al．Effect of resveratrol on modulation of endothelial cells and macrophages for rapid vascular regeneration from electrospun poly(εcaprolactone) scaffolds \[J\]. ACS Appl Mater Interfaces, 2017, 9(23):19541-19551.

［19］Yang L, Zhang Z, Zhuo Y, et al．Resveratrol alleviates sepsisinduced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells \[J\]. Am J Transl Res, 2018, 10(7):1961-1975.

［20］Kim GY, Cho H, Ahn SC, et al．Resveratrol inhibits phenotypic and functional maturation of murine bone marrowderived dendritic cells \[J\]. Int Immunopharmacol, 2004, 4(2):245-253.

［21］Buttari B, Profumo E, Facchiano F, et al．Resveratrol prevents dendritic cell maturation in response to advanced glycation end products \[J\]. Oxid Med Cell Longev, 2013, 2013:574029.

［22］Svajger U, Obermajer N, Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation\[J\]. Immunology, 2010, 129(4):525-535.

［23］Li Q, Huyan T, Ye LJ, et al．Concentrationdependent biphasic effects of resveratrol on human natural killer cells in vitro\[J\]. J Agric Food Chem, 2014, 62(45):10928-10935.

［24］Abdallah DM, Ismael NR. Resveratrol abrogates adhesion molecules and protects against TNBSinduced ulcerative colitis in rats\[J\]. Can J Physiol Pharmacol, 2011, 89(11):811-818.

［25］Yildiz G, Yildiz Y, Ulutas PA, et al. Resveratrol pretreatment ameliorates TNBS colitis in rats \[J\]. Recent Pat Endocr Metab Immune Drug Discov, 2015, 9(2):134-140.

［26］Arslan A, Ozcicek F, Keskin Cimen F, et al. Protective effect of resveratrol against methotrexateinduced oxidative stress in the small intestinal tissues of rats\[J\]. Int J Clin Exp Med, 2015, 8(7):10491-10500.

［27］Abdin AA. Targeting sphingosine kinase 1 (SphK1) and apoptosis by colonspecific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats\[J\]. Eur J Pharmacol, 2013, 718(1/3)145-153.

［28］Larrosa M, YaézGascón MJ, Selma MV, et al. Effect of a low dose of dietary resveratrol on colon microbiota, inflammation and tissue damage in a DSSinduced colitis rat model\[J\]. J Agric Food Chem, 2009, 57(6):2211-2220.

［29］Rahal K, SchmiedlinRen P, Adler J, et al. Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycanpolysaccharide rat model of Crohns disease\[J\]. Inflamm Bowel Dis, 2012, 18(4):613-623.

［30］Sharma M, Mohapatra J, Wagh A, et al. Involvement of TACE in colon inflammation: a novel mechanism of regulation via SIRT1 activation\[J\]. Cytokine, 2014, 66(1):30-39.

［31］Yao J, Wang JY, Liu L, et al. Antioxidant effects of resveratrol on mice with DSSinduced ulcerative colitis\[J\]. Arch Med Res, 2010, 41(4):288-294.

［32］Youn J, Lee JS, Na HK, et al. Resveratrol and piceatannol inhibit iNOS expression and NFκB activation in dextran sulfate sodiuminduced mouse colitis\[J\]. Nutr Cancer, 2009, 61(6):847-854.

［33］Altamemi I, Murphy EA, Catroppo JF, et al. Role of microRNAs in resveratrolmediated mitigation of colitisassociated tumorigenesis in ApcMin/+ mice\[J\]. J Pharmacol Exp Ther, 2014, 350(1):99-109.

［34］SamsamiKor M, Daryani NE, Asl PR, et al. Antiinflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, doubleblind, placebocontrolled pilot study\[J\]. Arch Med Res, 2015, 46(4):280-285.

［35］Samsamikor M, Daryani NE, Asl PR, et al. Resveratrol supplementation and oxidative/antioxidative status in patients with ulcerative colitis: a randomized, doubleblind, placebocontrolled pilot study\[J\]. Arch Med Res, 2016, 47(4):304-309.

［36］于锦超，于敏，莫炜．NFκB信号通路在肿瘤发生和炎症反应中的作用 \[J\]．药物生物技术，2016，23(1): 82-85.

［37］Cianciulli A， Calvello R， Cavallo P，et al．Modulation of NFκB activation by resveratrol in LPS treated human intestinal cells results in downregulation of PGE2 production and COX2 expression \[J\]．Toxicol in Vitro, 2012，26(7): 1122-1128.

［38］李金，张亚历．白藜芦醇在抑制炎症信号的转导通路方面的研究进展\[J\]．神经解剖学杂志，2012，28（2）：187-190．

［39］Yeung F，Hoberg JE，Ramsey CS，et al．Modulation of NFkappaBdependent transcription and cell survival by the SIRT1 deacetylase \[J\]．EMBO J, 2004，23 (12) :2369-2380．

［40］Singh UP, Singh NP, Singh B, et al．Resveratrol (trans3，5，4trihydroxystilbene) induces silent mating type information regulation1 and downregulates nuclear transcription factorkappaB activation to abrogate dextran sulfate sodiuminduced colitis\[J\]．J Pharmacol Exp Ther, 2010，332(3) : 829-839.

［41］Dong W，Li F，Pan Z，et al．Resveratrol ameliorates subacute intestinal ischemiareperfusion injury\[J\]．J Surg Res，2013，185(1): 182-189.

［42］Tsai SH，LinShiau SY，Lin JK．Suppression of nitric oxide synthase and the downregulation of the activation of NFkappaB in macrophages by resveratrol\[J\]．Br J Pharmacol, 1999，126 (3): 673-680．

［43］Chan MM，Mattiacci JA，Hwang HS，et al．Synergy between ethanol and grape polyphenols，quercetin，and resveratrol，in the inhibition of the inducible nitric oxide synthase pathway\[J\]．Biochem Pharmacol, 2000，60 (10) : 1539-1548．

［44］Ergün O，Ergün G，Oktem G，et al．Enteral resveratrol supplementation attenuates intestinal epithelial inducible nitric oxide synthase activity and mucosal damage in experimental necrotizing enterocolitis \[J\]．J Pediatr Surg, 2007，42 (10): 1687-1694．

［45］Shi Y, Zhou J, Jiang B，et al．Resveratrol and inflammatory bowel disease\[J\]. Ann N Y Acad Sci, 2017, 1403(1):38-47.

［46］Serra D，Rufino AT，Mendes AF，et al．Resveratrol modulates cytokineinduced Jak/STAT activation more efficiently than 5aminosalicylic acid: an in vitro approach\[J\]．PLoS One, 2014，9(10) : e109048．

［47］Jang DS，Kang BS，Ryu SY，et al．Inhibitory effects of resveratrol analogs on unopsonized zymosaninduced oxygen radical production \[J\]．Biochem Pharmacol, 1999，57（6）：705-712．

［48］Yildiz F，Terzi A，Coban S，et al．Protective effects of resveratrol on small intestines against intestinal ischemiareperfusion injury in rats\[J\]．J Gastroenterol Hepatol, 2009，24（11）：1781-1785．

［49］Ozkan OV，Yuzbasioglu MF，Ciralik H，et al．Resveratrol，a natural antioxidant， attenuates intestinal ischemia／reperfusion injury in rats \[J\]．Tohoku J Exp Med, 2009，218（3）：251-258．

［50］Jha RK，Ma Q，Lei Z，et al. Resveratrol ameliorates the deleterious effect of severe acute pancreatitis \[J\]．Cell Biochem Biophys, 2012，62( 2) : 397-402．

［51］Sahebally SM，Burke JP，Chang KH，et al．Circulating fibrocytes and Crohns disease\[J\]．Br J Surg, 2013，100(12) : 1549-1556．

［52］Rahal K，SchmiedlinRen P，Adler J，et al．Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycanpolysaccharide rat model of Crohns disease\[J\]．Inflamm Bowel Dis, 2012，18(4) : 613-623．

［53］Garcia P，SchmiedlinRen P，Mathias JS，et al. Resveratrol causes cell cycle arrest，decreased collagensynthesis，and apoptosis in rat intestinal smooth muscle cells\[J\]．Am J Physiol Gastrointest Liver Physiol, 2012，302(3): G326-G335．

［54］Li P，Liang ML，Zhu Y，et al．Resveratrol inhibits collagen I synthesis by suppressing IGF1R activation in intestinal fibroblasts\[J\]．World J Gastroenterol, 2014，20(16) : 4648-4661．

［55］Chu H, Jiang S, Liu Q，et al. Sirtuin1 protects against systemic sclerosisrelated pulmonary fibrosis by decreasing proinflammatory and profibrotic processes\[J\].Am J Respir Cell Mol Biol, 2018, 58(1):28-39.